These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 16288002

  • 1. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.
    Reddy HK, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP.
    Cancer Res; 2005 Nov 15; 65(22):10174-8. PubMed ID: 16288002
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
    Renner O, Blanco-Aparicio C, Grassow M, Cañamero M, Leal JF, Carnero A.
    Cancer Res; 2008 Dec 01; 68(23):9643-53. PubMed ID: 19047141
    [Abstract] [Full Text] [Related]

  • 5. Requirement for CDK4 kinase function in breast cancer.
    Yu Q, Sicinska E, Geng Y, Ahnström M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, Stål O, Sicinski P.
    Cancer Cell; 2006 Jan 01; 9(1):23-32. PubMed ID: 16413469
    [Abstract] [Full Text] [Related]

  • 6. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q, Geng Y, Sicinski P.
    Nature; 2001 Jun 28; 411(6841):1017-21. PubMed ID: 11429595
    [Abstract] [Full Text] [Related]

  • 7. Role of SRC kinases in Neu-induced tumorigenesis: challenging the paradigm using Csk homologous kinase transgenic mice.
    Kaminski R, Zagozdzon R, Fu Y, Mroz P, Fu W, Seng S, Avraham S, Avraham HK.
    Cancer Res; 2006 Jun 01; 66(11):5757-62. PubMed ID: 16740714
    [Abstract] [Full Text] [Related]

  • 8. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG, Xu X, Li C, Kuo A, Leder P, Deng CX.
    Oncogene; 2001 Mar 22; 20(12):1445-54. PubMed ID: 11313888
    [Abstract] [Full Text] [Related]

  • 9. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 10. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 11. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
    Bowe DB, Kenney NJ, Adereth Y, Maroulakou IG.
    Oncogene; 2002 Jan 10; 21(2):291-8. PubMed ID: 11803472
    [Abstract] [Full Text] [Related]

  • 12. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 10; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 13. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
    Muraoka RS, Lenferink AE, Law B, Hamilton E, Brantley DM, Roebuck LR, Arteaga CL.
    Mol Cell Biol; 2002 Apr 10; 22(7):2204-19. PubMed ID: 11884607
    [Abstract] [Full Text] [Related]

  • 14. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Qiu C, Shan L, Yu M, Snyderwine EG.
    Cancer Res; 2003 Sep 15; 63(18):5674-8. PubMed ID: 14522882
    [Abstract] [Full Text] [Related]

  • 15. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 16. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
    Gardner HP, Ha SI, Reynolds C, Chodosh LA.
    Cancer Res; 2000 Oct 01; 60(19):5571-7. PubMed ID: 11034105
    [Abstract] [Full Text] [Related]

  • 17. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.
    Cancer Res; 2003 Jun 15; 63(12):3395-402. PubMed ID: 12810676
    [Abstract] [Full Text] [Related]

  • 18. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT, Leder P.
    Oncogene; 1998 Feb 12; 16(6):737-46. PubMed ID: 9488037
    [Abstract] [Full Text] [Related]

  • 19. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y, Thakur A, Sun Y, Wu J, Biliran H, Bollig A, Liao DJ.
    Cancer Res; 2007 Apr 15; 67(8):3698-707. PubMed ID: 17440082
    [Abstract] [Full Text] [Related]

  • 20. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
    Klein A, Guhl E, Tzeng YJ, Fuhrhop J, Levrero M, Graessmann M, Graessmann A.
    Oncogene; 2003 May 15; 22(19):2910-9. PubMed ID: 12771941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.